Related Experiment Video
Updated: Aug 11, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C: a review for primary care physicians
1Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada and the University of Ottawa, Ottawa, Ont. tom_wong@hc-sc.gc.ca
Insights
Many Canadians with chronic hepatitis C virus (HCV) are unaware of their infection, contributing to a hidden epidemic. Early detection and antiviral therapy are crucial for treatment and preventing spread.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- An estimated 250,000 Canadians have chronic Hepatitis C Virus (HCV) infection.
- Approximately one-third of infected individuals are unaware of their status, fueling a significant hidden epidemic.
- Asymptomatic nature of HCV necessitates risk factor assessment and patient testing.
Purpose of the Study:
- To highlight the prevalence of undiagnosed chronic Hepatitis C Virus (HCV) in Canada.
- To emphasize the importance of screening and early diagnosis in primary care settings.
- To review current diagnostic methods and treatment strategies for HCV.
Main Methods:
- Review of diagnostic tests including third-generation enzyme immunoassay for HCV antibodies and HCV RNA polymerase chain reaction (PCR) testing.
- Discussion of combination therapy with pegylated interferon-alpha and ribavirin.
- Examination of preventive strategies and counseling recommendations.
Main Results:
- Third-generation enzyme immunoassay is a sensitive and specific test for HCV antibodies.
- HCV RNA PCR can confirm viral presence in specific cases.
- Pegylated interferon-alpha and ribavirin therapy achieves viral clearance in 45%-80% of patients, varying by genotype.
Conclusions:
- Primary care physicians play a vital role in identifying and managing chronic HCV infections.
- Increased awareness, risk factor assessment, and timely testing are essential to combat the hidden HCV epidemic.
- Effective antiviral therapies are available, offering a cure for a significant proportion of infected individuals.
Abstract:
Primary care physicians see many of the estimated 250 000 Canadians chronically infected with the hepatitis C virus (HCV). Of this number, about one-third are unaware they are infected, which constitutes a large hidden epidemic. They continue to spread HCV unknowingly and cannot benefit from advances in antiviral therapy that may clear them of the virus. Many HCV-infected people remain asymptomatic, which means it is important to assess for risk factors and test patients accordingly. The third-generation enzyme immunoassay for HCV antibodies is a sensitive and specific test, although the presence of the virus can be confirmed by polymerase chain reaction testing for HCV RNA in some circumstances. Pegylated interferon-alpha and ribavirin combination therapy clears the virus in about 45%-80% of patients, depending on viral genotype. Preventive strategies and counselling recommendations are also reviewed.
Related Concept Videos
01:25Hepatitis
01:28Viral Hepatitis I: Introduction
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test